u/emil_agyeman
Contributes reviews on supplier material. Based in Rosario.
member · joined 13 Apr 2025
Comments — page 5 of 5
comment on what changed for me between week 45 and week 88 in c/coa · 575 points · 9 months ago
comment on Canada: dose history, and what it actually costs here in c/dosinglogs · 24 points · 9 months ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on [PSA] ALT is not what most of this community thinks it is in c/bloodwork · 31 points · 9 months ago
ALT is where the fatty-liver story shows up first
comment on [PSA] ALT is not what most of this community thinks it is in c/bloodwork · 4 points · 9 months ago
Yeah, baseline matters more than any later number.
comment on [PSA] ALT is not what most of this community thinks it is in c/bloodwork · 22 points · 9 months ago
eGFR noise on rapid loss is real. 20 week noise, 38 week trend. Do not panic at week 26.
comment on what would you tell week-1 you about SURMOUNT in c/trialwatch · 434 points · 10 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on the Netherlands: dose history, and what it actually costs here in c/dosinglogs · 1 points · 10 months ago
Did anything else change in the same window?
comment on [Discussion] can we stop arguing about mechanism until somebody posts a number in c/glp1science · 20 points · 10 months ago
amylin is not GLP-1, posts conflating them get corrected
comment on does glucagon actually matter or is it forum lore at this point in c/retatrutide · 299 points · 11 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on does glucagon actually matter or is it forum lore at this point in c/retatrutide · 289 points · 11 months ago
retatrutide is not approved anywhere for human use, posts must not read as instructions
comment on genuine question about appetite that I am slightly embarrassed to ask in c/glp1science · 1 points · 11 months ago
the 17-day half-life means week 17 is still ramp-up pharmacokinetically
comment on tried reship for 19 weeks. here is what happened. in c/intlshipping · 1 points · 11 months ago
Actual days or estimated?
comment on tried PeptideMeter for 23 weeks. here is what happened. in c/labresults · 4 points · 1 year ago
Which Medutest service and what method did they use?
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on three years of amylin threads, summarised so you do not have to read them in c/cagrilintide · 1 points · 1 year ago
[deleted]
Yes, exactly this, and it is the bit that took me 32 weeks to accept.
comment on 18 months in and hazard ratio is still the thing I get wrong in c/trialwatch · 67 points · 1 year ago
give the trial name, phase, n, and primary endpoint in the body
comment on help me understand reship, I have read the wiki twice in c/intlshipping · 1 points · 1 year ago
packaging quality matters on the 4-hour segments
comment on does batch actually matter or is it forum lore at this point in c/coa · 9 points · 1 year ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
Adding to this: certificate of analysis is doing more work than the comment implies.
comment on satiety — 14 things I got wrong before I got it right in c/cagrilintide · 2 points · 1 year ago
amylin receptor distribution is different from GLP-1
comment on [Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2% in c/retatrutide · 1 points · 1 year ago
the glucagon component changes the side effect profile, not just the efficacy
comment on help me understand waist, I have read the wiki twice in c/dosinglogs · 21 points · 1 year ago
dose, date, weight, waist, early fullness, labs